Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
Clinical trial NCT01629758 · COMPLETED
Trial details
- NCT number
- NCT01629758
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.